Impact of SGLT2 inhibitors treatment on the chronic kidney disease in people with type 2 diabetes

Diabetes is the most common cause of CKD (chronic kidney disease). CKD is also one of the most important diabetic complication. SGLT2 (sodium glucose co‐transporter‐2) inhibitors are new class of medication used to lower high blood glucose level in people with type 2 diabetes. In new researches SGL...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Marcin Czarkowski, Karolina Raksa, Ewelina Powroźniak, Karol Spozowski
Format:	Artigo
Sprog:	Inglês
Udgivet:	Kazimierz Wielki University 2022-09-01
Serier:	Journal of Education, Health and Sport
Fag:	SGLT2 sodium glucose co‐transporter‐2 inhibitors type 2 diabetes chronic kidney disease
Online adgang:	https://apcz.umk.pl/JEHS/article/view/39675
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!